The Dangers of E-Cigarettes: A Growing Health Risk in Brazil

Aug.15.2022
The Dangers of E-Cigarettes: A Growing Health Risk in Brazil
Brazil bans the commercialization, production, import and promotion of e-cigarettes due to their serious health risks.

In Brazil, it is illegal to commercialize, produce, import, or advertise electronic cigarettes due to the serious health risks they pose, which are higher than those of regular cigarettes. This ban has had a significant impact.


Although the legal limit for nicotine content in regular cigarettes is 1 milligram per unit, electronic cigarettes have reached up to 57 milligrams per unit without any regulation. Even if a person takes small puffs, they could end up consuming the equivalent of several packs of cigarettes.


The addictive and carcinogenic ingredients are several times higher, and there is also a greater risk of other diseases (such as chronic lung disease) and increased chances of heart attacks. There is even a new disease caused by this device: EVALI, which stands for electronic cigarette or vaping product use-associated lung injury.


E-cigarettes work by heating a combination of water and oil-based substances (such as tobacco oil or marijuana) using a battery, and converting it into an aerosol that is then inhaled and exhaled. This also puts other people who breathe in the vapor emitted from the device at risk, much like with traditional cigarette smoke.


More adherence to regular cigarettes.


Electronic cigarettes have become increasingly popular among young people and even children in the digital age due to their technological allure, as well as their tempting flavors and aromas that encourage the use of conventional cigarettes. This has been revealed in a study conducted by the National Cancer Institute (Inca) of the Ministry of Health (MS) based on 31 surveys carried out in multiple countries between 2016 and 2020.


According to Liz Almeida, a coordinator for Inca Prevention and Monitoring and an epidemiologist, electronic cigarettes increase the likelihood that non-smokers will start using traditional cigarettes, which slows down the decline of smokers in Brazil. Liz explains that the risk of using electronic cigarettes is over three times higher for trying traditional cigarettes and over four times higher for using one's own. Doctors state that this product exposes the body to various chemical elements: heating and evaporation release nanoparticles from the metal and heated substances in the device, such as the aforementioned nicotine and other carcinogens, as well as elements that cause lung and cardiovascular diseases.


Despite a ban by the health department on the commercialization, importation, and advertising of tobacco products in Brazil for over a decade (RDC 46, August 28, 2009), these products are easily accessible to the public nationwide through the internet, informal commerce, and even through so-called "tobacco merchants" - though they can only be purchased abroad while traveling.


The Secretary General of the World Health Organization, Ana Cristina Pinho, who is also an anesthetist, has issued a warning stating that smoking - regardless of whether through traditional or electronic means - is a disease. Pinho emphasized that smoking leads to chronic illnesses related to tobacco use, resulting in thousands of deaths each year. These illnesses include various types of lung, liver, stomach, pancreas, kidney, bladder, ovarian, cervical, nasal, sinus, oral, pharynx, esophagus, and acute myeloid leukemia cancers.


The Impact of TikTok


A large portion of young people and children who use electronic cigarettes are being influenced by the most popular social networks among their age group (mostly those under 25 years old), such as TikTok, according to a study conducted by the University of Queensland in Australia. The study indicates that smoking habits are being promoted positively.


A study in Australia analyzed over 78 million TikTok videos, which showed electronic cigarettes being used in a fun and creative way, including with music and dancing. Researchers even suggest that many of these posts may be sponsored by manufacturers and sellers, although this cannot yet be confirmed.


Some videos show how young people can hide their smoking habits and ways to conceal their smoking devices from parents and guardians, including at school and through airport security. As a response, a social network has announced that it will analyze its posts and remove those that encourage addiction.


Despite Brazil's laws that prohibit the use of electronic devices for smoking, the usage of such devices has increased and a majority of the population lacks legal awareness. More and more people in Brazilian cities are openly using electronic cigarettes on the streets.


The only possible method to quit smoking.


It is essential to understand addiction, regardless of its form, as a significant mental health issue. Therefore, treatment must also be focused on mental health, as taught in "The Treatment of Addiction" lectures held every Sunday in universal churches. Many seek help through this type of treatment to overcome their dependence on traditional cigarettes, e-cigarettes, hookah tobacco, and other addictive substances, while receiving support for themselves and their families.


Statement


This article is compiled from third-party information and is only intended for industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry exchange and research.


Due to limitations in our translation abilities, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.


2FIRSTS is fully aligned with the Chinese government's stance and statements on domestic, Hong Kong, Macau, Taiwan, and foreign issues.


The compilation of information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08